ArticleThe European respiratory journal2025
Reply to: Response and remission in asthma with tezepelumab: overlapping concepts informing on type-2 inflammatory-dependent treatment effects.
Neil Martin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.